Abeona Therapeutics (ABEO) Interest Expense - Others (2018 - 2022)
Abeona Therapeutics (ABEO) posted quarterly Interest Expense - Others of $200000.0 for Q1 2022, down 84.93% quarter-over-quarter from $1.3 million in Q3 2020.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Interest Expense - Others (2018 - 2022) Analysis & Trends
Abeona Therapeutics' Interest Expense - Others history runs 3 years deep, the most recent figure standing at $200000.0 for Q1 2022.
- In Q1 2022, Interest Expense - Others changed N/A year-over-year to $200000.0; the TTM figure through Mar 2022 stood at $1.5 million (changed N/A YoY), while the FY2021 annual figure was $67000.0, down 98.37% from the prior year.
- Interest Expense - Others for Q1 2022 stood at $200000.0, down from $1.3 million in the prior quarter.
- The five-year high for Interest Expense - Others was $1.3 million in Q3 2020, with the low at $2000.0 in Q4 2018.
- The 3-year median for Interest Expense - Others is $101500.0 (2018), against an average of $383000.0.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 200,000.00 |
| Sep 30, 2020 | 1.33 Mn |
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 3,000.00 |